Optimal Radiation Dose for Stage III Lung Cancer—Should “Definitive” Radiation Doses Be Used in the Preoperative Setting?

Introduction: There are currently two recommended radiation strategies for clinical stage III NSCLC: a lower “preoperative” (45–54 Gy) and a higher “definitive/nonsurgical” (60–70 Gy) dose. We sought to determine if definitive radiation doses should be used in the preoperative setting given that man...

Full description

Bibliographic Details
Main Authors:	Areo G. Saffarzadeh, MD, MS, Maureen Canavan, PhD, MPH, Benjamin J. Resio, MD, Samantha L. Walters, MHS, Kaitlin M. Flores, Roy H. Decker, MD, PhD, Daniel J. Boffa, MD
Format:	Article
Language:	English
Published:	Elsevier 2021-08-01
Series:	JTO Clinical and Research Reports
Subjects:	Non–small cell lung cancer (NSCLC) Radiation dose Stage III National Cancer Database (NCDB) Chemoradiotherapy Neoadjuvant
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666364321000606

Internet

http://www.sciencedirect.com/science/article/pii/S2666364321000606

Optimal Radiation Dose for Stage III Lung Cancer—Should “Definitive” Radiation Doses Be Used in the Preoperative Setting?

Internet

Similar Items